RANKINGS
Lowest EV/EBITDA — Healthcare
Enterprise Value to EBITDA. Lower ratios may indicate undervaluation.
71 companies with EV/EBITDA data.
Ranked by EV/EBITDA(71)
| # | Ticker | Name | Market Cap | EV/EBITDA |
|---|---|---|---|---|
| 1 | MTEX | $9M | 0.2 | |
| 2 | VHI | $399M | 2.0 | |
| 3 | USNA | $342M | 2.0 | |
| 4 | OPK | $888M | 3.4 | |
| 5 | BTMD | $60M | 3.6 | |
| 6 | KRO | $748M | 4.5 | |
| 7 | SNYR | $7M | 5.5 | |
| 8 | FMC | $2.2B | 5.7 | |
| 9 | PTCT | $6.0B | 6.2 | |
| 10 | CBT | $3.9B | 6.3 | |
| 11 | BHC | $2.1B | 6.7 | |
| 12 | FTLF | $87M | 6.8 | |
| 13 | SRPT | $2.3B | 7.4 | |
| 14 | SCL | $1.2B | 8.3 | |
| 15 | ADMA | $2.5B | 8.5 | |
| 16 | OLN | $3.2B | 8.8 | |
| 17 | FSI | $67M | 8.8 | |
| 18 | LXFR | $354M | 9.4 | |
| 19 | LNTH | $5.4B | 9.8 | |
| 20 | EMN | $8.4B | 9.8 | |
| 21 | RMTI | $37M | 9.9 | |
| 22 | TEVA | $37.0B | 10.1 | |
| 23 | FUL | $3.4B | 10.1 | |
| 24 | BMY | $118.6B | 10.1 | |
| 25 | PPG | $24.7B | 10.7 | |
| 26 | SEE | $6.2B | 10.9 | |
| 27 | CLX | $12.6B | 10.9 | |
| 28 | BIIB | $26.3B | 11.3 | |
| 29 | IPAR | $3.1B | 11.6 | |
| 30 | PFE | $154.2B | 12.0 | |
| 31 | AVNT | $3.5B | 12.4 | |
| 32 | SLSN | $78M | 13.1 | |
| 33 | REGN | $79.9B | 13.5 | |
| 34 | SMG | $3.6B | 13.7 | |
| 35 | MRK | $296.3B | 13.7 | |
| 36 | AMGN | $189.2B | 13.9 | |
| 37 | EPC | $1.0B | 13.9 | |
| 38 | UTHR | $25.4B | 14.5 | |
| 39 | JNJ | $578.3B | 14.8 | |
| 40 | RPM | $13.9B | 15.0 | |
| 41 | PG | $335.5B | 15.1 | |
| 42 | LXU | $994M | 15.2 | |
| 43 | CL | $67.5B | 15.8 | |
| 44 | BMRN | $10.7B | 15.9 | |
| 45 | MNKD | $846M | 16.8 | |
| 46 | IFF | $18.5B | 16.9 | |
| 47 | SXT | $4.0B | 17.3 | |
| 48 | ABT | $175.6B | 17.3 | |
| 49 | CHD | $22.6B | 18.8 | |
| 50 | HALO | $8.0B | 20.1 | |
| 51 | PAHC | $2.4B | 20.2 | |
| 52 | COTY | $2.0B | 20.2 | |
| 53 | RIGL | $580M | 20.5 | |
| 54 | JAZZ | $12.4B | 21.4 | |
| 55 | ANIP | $1.8B | 22.6 | |
| 56 | ECL | $77.1B | 23.7 | |
| 57 | WDFC | $2.8B | 24.6 | |
| 58 | HXL | $6.4B | 24.8 | |
| 59 | LLY | $824.1B | 30.0 | |
| 60 | IDXX | $46.4B | 30.9 | |
| 61 | TECH | $9.2B | 43.2 | |
| 62 | FTK | $568M | 43.2 | |
| 63 | ALB | $22.4B | 46.7 | |
| 64 | APD | $66.0B | 55.4 | |
| 65 | ARWR | $9.3B | 69.7 | |
| 66 | ICCC | $70M | 73.2 | |
| 67 | FOLD | $4.5B | 87.7 | |
| 68 | GILD | $174.3B | 93.2 | |
| 69 | TGTX | $5.5B | 112.4 | |
| 70 | BCRX | $2.4B | 205.8 | |
| 71 | EL | $27.6B | 219.4 |
How to turn this ranking into valuation work
Start with the company page
Validate business quality, margins, capital structure, and the current valuation context before relying on a single multiple.
Then validate WACC
A cheap multiple does not guarantee a sensible discount rate. Check cost of capital before finalizing DCF assumptions.
Finish with DCF
Use the matching DCF page to test intrinsic value so multiples, discount rates, and cash-flow assumptions stay connected.
EV/EBITDA Rankings in Other Sectors
Data updated daily · Source: SEC EDGAR, Polygon.io